drugset
Drugs / HER2-specific T cells
last change Apr 2022 re-read 3 minutes ago

HER2-specific T cells

Cell therapy

Developed for
brain cancer
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

Trials 1

today NCT02442297 · Ph 1
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02442297 Apr 2016 → Apr 2022 overdue brain cancer Baylor College of Medicine Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HER2-specific T cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT02442297 ↗
Action Deplete “These CAR-T cells seem to be able to kill tumors like the one these patients have” NCT02442297 ↗
Modality Cell therapy “These CAR-T cells seem to be able to kill tumors like the one these patients have” NCT02442297 ↗